PixarBio
PixarBio Corp is a publicly traded specialty biotechnology company focused on pre-clinical and commercial development of new products, headquartered in Medford, United States. Founded in 2013, the firm trades on the OTCQX market under PXRB.
- Company typePrivate
- Founded2013
- HeadquartersMedford, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What PixarBio does
PixarBio Corp is a publicly traded specialty biotechnology company headquartered in Medford, United States. Founded in 2013 and trading on the OTCQX market under the ticker PXRB, the company is described in its own firmographic profile as focused on the pre-clinical and commercial development of new products. Per available firmographic data, the firm operates as a for-profit entity with 11-50 employees.
Leadership is concentrated in a three-founder structure. Frank Reynolds is listed as Chairman of the Board and concurrently holds the CEO, CFO, and CSO titles. Jason Criscione is CTO and co-founder, and Katrin Holzhaus is co-founder and COO. The consolidation of executive functions in a single founder is consistent with a small, founder-led development-stage biotech rather than a scaled commercial organization, and signals limited operational headcount beyond the founding team.
The available input discloses two financing rounds dated November 18, 2016 totaling $17 million ($10 million and $7 million) as the only dated capital-markets activity. No revenue, products or services, partnerships, customers, patent portfolio, awards, regulatory actions, M&A, or recent product launches are present in the source material. Separately, a large structured data block labeled under PixarBio describes CGI animation technology, theatrical releases, merchandise partnerships, and Disney distribution — these statements pertain to Pixar Animation Studios, a wholly separate Disney-owned entity, and are not characteristics of PixarBio Corp.
PixarBio firmographics
Firmographics- Name
- PixarBio
- Website
- https://pixarbio.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- PixarBio Corp is a publicly traded specialty biotechnology company focused on pre-clinical and commercial development of new products, headquartered in Medford, United States. Founded in 2013, the firm trades on the OTCQX market under PXRB.
- Ownership category
- akta.pro rank
PixarBio industry classification
Industry- Product category
- Specialty Biotechnology
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)
- akta.pro secondary industry
- GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL)
Keywords
Where PixarBio is headquartered
LocationHeadquarters
- HQ city
- Medford
- HQ country
- United States
- HQ region
- North America
Markets served
PixarBio business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations
Distribution channels3 records
Marketing channels4 records
PixarBio product offering
Product offeringCore offering
PixarBio Corp is a specialty biotechnology company focused on pre-clinical and commercial development of new products. The company engages in research and development activities to advance therapeutic candidates through pre-clinical stages and toward commercialization within the specialty biotechnology sector.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- Toy Story 5 set for theatrical release June 19, 2026
- +4 more outcomes
Companies that use PixarBio
Customer profileSegments1 record
Ideal customer profiles1 record
PixarBio technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
PixarBio partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered minor and core.
- FunkominorFunko unveiled Toy Story 5 Funko Pop figurines featuring updated versions of Woody, Buzz Lightyear, Jessie, and new character Lilypad. Standard vinyl figures priced at $14.88 each, plus blind box-style Funko Mystery Mini Packs with 12 characters.
- Fresh Del MonteminorFresh Del Monte launched a global marketing campaign in partnership with Disney and Pixar's Toy Story 5, featuring co-branded packaging on bananas and pineapples across more than 90 countries. The campaign includes in-store activations, digital promotions, and sweepstakes offering grocery shoppers a five-night trip to Barcelona.
- Dr. Squatch and JukeboxminorDr. Squatch and Jukebox launched a limited-edition grooming collection in collaboration with Disney and Pixar inspired by Toy Story 5, featuring bar soaps and deodorants. Collection priced from $8 for individual bars to $48.45 for a 5-pack, available ahead of film's June 19, 2026 release.
- Newell Brands (Sharpie and Elmer's)minorSharpie and Elmer's, brands under Newell Brands, launched a limited-edition collection of markers, glue sticks, and slime kits inspired by Toy Story 5, featuring Woody, Buzz Lightyear, and Jessie on product packaging. Products available at Amazon, Walmart, and Target, priced from $3.47 to $29.99 MSRP.
- MattelcoreDisney and Pixar released Toy Story 5 on June 19 accompanied by an extensive toy line developed in partnership with Mattel. The new toy line features advanced technology including animatronics and interactive features, representing the biggest technological leap for Mattel in their toy designs.
- ESPN/NFLminorNFL, Disney, Pixar, ESPN, Sony, and Hawk-Eye Innovations collaborated to present Monsters Funday Football, a real-time animated NFL game featuring Philadelphia Eagles and Los Angeles Chargers in the world of Monsters, Inc.
- Epic Games (Fortnite)minorDisney leveraged unexpected viral momentum for Hoppers through Fortnite crossover content with Epic Games, along with influencer events and Super Bowl broadcasts.
- FandangominorDr. Squatch partnered with Fandango to offer a $5 promo code toward movie tickets for qualifying purchases of Toy Story 5-inspired products.
Recent moves2 records
Expansion highlights1 record
PixarBio competitors and assessment
Company assessmentBroad incumbents
- Charles River Laboratories: Large CRO with deep pre-clinical and discovery services offerings; comparable as a broader incumbent operating in the pre-clinical development space that PixarBio's pipeline implicitly depends on.
- Inotiv: Established contract research/pre-clinical services platform supporting drug development; broadly comparable to PixarBio's pre-clinical development orientation, though larger and services-model rather than asset-owning.
- Ligand Pharmaceuticals: Public specialty pharma with a portfolio of royalty/milestone-driven assets; comparable as a publicly traded specialty pharmaceutical business model, though significantly larger and more diversified than PixarBio.
- Maravai LifeSciences: Public specialty life-sciences tools and services provider; comparable as a public specialty life-sciences company with a similar small-mid cap profile but broader commercial reach.
Emerging players
- Bionova Scientific: Emerging CDMO/biologics development services provider serving pre-clinical biotech clients; comparable as a small specialized biotech-services peer in the broader pre-clinical ecosystem.
Direct peers
- Aytu BioPharma: Small-cap public specialty pharmaceutical company; comparable to PixarBio as a publicly traded specialty pharma with limited headcount and a development-stage product portfolio.
- Aprea Therapeutics: Small-cap U.S. specialty oncology/pre-clinical biotech listed on Nasdaq, comparable to PixarBio as a publicly traded developer of a focused pipeline asset with limited headcount.
- Codexis: Public specialty biotech / enzyme engineering company; comparable as a small public specialty biotech pursuing platform-based product development rather than single-asset generic play.
- BioRestorative Therapies: Small public biotech focused on specialty pre-clinical and early-commercial development; directly comparable to PixarBio in stage, scale, and specialty biotech orientation.
- Tonix Pharmaceuticals: Small-cap U.S. public specialty pharmaceutical company developing pre-clinical and clinical-stage specialty therapeutics; directly comparable to PixarBio as a publicly listed specialty pharma of similar scale.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat1 record
Key risks5 records
Key highlights5 records
Customer concentration
PixarBio social profiles
Digital presencePixarBio financial estimates
Financial estimateRevenue estimate
Valuation estimate
PixarBio leadership team
Management profileNumber of profiles
Profiles3 records
PixarBio funding detail
Funding detailFunding overview
Funding rounds2 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PixarBio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PixarBio
What does PixarBio do?
PixarBio Corp is a specialty biotechnology company focused on pre-clinical and commercial development of new products. The company engages in research and development activities to advance therapeutic candidates through pre-clinical stages and toward commercialization within the specialty biotechnology sector.
Is PixarBio a public or private company?
PixarBio is a private company. It is classified as public and is currently operating.
When was PixarBio founded?
PixarBio was founded in 2013. It employs 11 to 50 people.
Where is PixarBio based?
PixarBio is headquartered in Medford, United States, in the North America region.
Who are PixarBio's main competitors?
Broad incumbents on record are Charles River Laboratories, Inotiv, Ligand Pharmaceuticals and Maravai LifeSciences. Bionova Scientific is listed as an emerging player. Direct peers are Aytu BioPharma, Aprea Therapeutics, Codexis, BioRestorative Therapies and Tonix Pharmaceuticals.
Does PixarBio have an API?
No public API is recorded for PixarBio.
What industry is PixarBio in?
PixarBio's product category is Specialty Biotechnology. Its primary akta.pro industry code is HLAIAAAA, Primary Care & General Medicine Pharmaceuticals, with a secondary code of HLAGAHAL, GMP Scale-Up, Tech Transfer & Process Validation (PPQ). Its NAICS code is 541714 and its SIC code is 2834.